Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

Dutch biotech UniQure has won orphan drug designation (ODD) for its investigational treatment for Huntington’s Disease, a rare, inherited neurodegenerative disorder that leads to loss of muscle ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

French pharma company Servier and biopharma company Oncodesign have reach the first milestone in their collaboration on research and development into new drug candidates for Parkinson’s disease. In a ...

The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab). The rare bleeding disorder treatment, which is cleared in the EU for routine ...

Healthcare communications network McCann Health has announced the promotion of Adriano Botter (pictured above) to global chief digital officer. Prior to taking on the new role, Botter was digital ...

Gilead has posted its results for the first quarter of 2021, noting an increase in revenues for the quarter, driven by its COVID-19 pill Veklury, while sales of its HIV drugs took a hit. The total ...

Merck & Co has submitted its single-tablet combination therapy for hepatitis C virus (HCV) to the US FDA as it tries to catch up with the leading players in the all-oral therapy sector. Merck – known ...

Communications giant FCB Health Network has announced the launch of Area 23 On Hudson, a realigned offering that combines Hudson Global’s medical communication expertise with Area 23’s agency services ...

Manchester, UK-based medical communications agency Couch has marked its second birthday with a rebrand. Two years after launch, Couch co-owners Ash and Katie Rishi have consolidated their offering ...

Germany’s cost regulator has decided there is no evidence for an added benefit of Novartis’s Cosentyx in ankylosing spondylitis and psoriatic arthritis compared to established drugs. The Institute for ...

Liberation Unlimited has further strengthened its team with the addition of Hayley Jayawardene as senior account director. Jayawardene joins after freelancing-in-house at Pfizer and at medical ...